|

| Sign up
for our e-mail list for updates and socially responsible
job listings. |
|
|
Student
Pugwash USA
1015 18th St. NW
Suite 704
Washington, DC 20036
Tel: 202 429-8900
1-800-969-2784
Fax: 202 429-8905
spusa@spusa.org
www.spusa.org |
|
|
|
Scientific Research Funding
Ethical Questions
1. You are a Representative on the House Committee
for Science. A bill comes before you arguing that the public should
have total and free access to all results of scientific research
paid for by the federal government. The bill comes under the auspice
that taxpayer dollars paid for the research, and therefore the information
obtained from that research, belongs to the citizens and taxpayers.
What are some of the risks and disadvantages to such a bill? Do
you think that the public should have free and unlimited access
to scientific research that it funds? What are the national security
implications of such a bill? What are the implications for scientific
openness?
2. You are a Senator in your second term and are playing an integral
role in the Senate's budgetary process. As part of this process,
you are faced with making a decision about the allocation of federal
dollars for scientific research. One of your colleagues argues that
the money would be used more efficiently if it were given to private
industry and universities, allowing them to choose what to research
and how. Another, however, believes that the government should require
research to be conducted on infectious diseases that are no longer
of any real threat within the United States, yet still kill millions
of people worldwide, such as tuberculosis and malaria. He believes
that giving the money to private industry will not cure these diseases
because of a lack of market demand within the US to conduct such
research. What course should the government take? Do we have an
obligation to help rid the rest of the world of infectious diseases?
Is it right for the government to make this decision, instead of
leaders in the private sector? If the money is spent by private
industry for research into drugs like Viagra, has the money been
effectively spent?
3. Imagine you are a newly hired research professor working for
a public university (University of Michigan, for example). You have
a background in medicine and psychiatry and just received your first
job as a researcher. You are approached by a pharmaceutical company
attempting to determine the medicinal benefits of marijuana and
other illegal drugs. The pharmaceutical company tells you that it
wants a favorable study of marijuana's medical effects; however,
your research is inconclusive in this area. The company tells you
that if the results of the study do not match their interests, you
will lose funding on other projects that could be very beneficial
for curing other diseases and for your university's standing in
the research community. Is it acceptable to say that marijuana has
positive effects in order to secure more funding for other research
projects that could save lives? Should pharmaceutical companies
be in a position to make demands like the one above? If not, how
can we avoid situations like this one? Keep in mind that future
money could potentially help to cure diseases and determine the
actual benefits (if there are any) of medicinal marijuana. What
are the implications of a demand like the one made above by a private
company?
|
|